Dr David Rosmarin, MD, explores the treatment landscape and clinical burden associated with vitiligo.
EP. 1: Understanding Pathology and Prevalence of Vitiligo
David Rosmarin, MD, provides insights on vitiligo and its prevalence among the patient population.
Watch
EP. 2: Economic Burden and Quality Life Impacted by Vitiligo
David Rosmarin, MD, illustrates the impacts of vitiligo on patient quality of life.
EP. 3: Overview of Vitiligo Treatment Landscape
Dr Rosmarin gives a brief overview of treatment pathways.
EP. 4: Considerations for Various Vitiligo Treatment Strategies
Dr Rosmarin explores several treatment approaches for vitiligo, including specific options for oral repigmentation treatments.
EP. 5: Role of JAK Inhibitors in Vitiligo Treatment
JAK inhibitors’ effectiveness as a frontline treatment option for vitiligo is discussed by a key opinion leader in vitiligo treatment.
EP. 6: Clinical Studies Supporting Ruxolitinib Cream for Frontline Vitiligo Treatment
Dr Rosmarin describes the impacts of ruxolitinib on the treatment strategies for vitiligo.
EP. 7: Payer Considerations for Vitiligo Treatment Coverage
Payer perspectives are considered for the treatment of vitiligo.
EP. 8: Exploring Unmet Needs and Pipeline Treatments for Vitiligo
Dr Rosmarin navigates unmet needs and the trajectory of vitiligo treatment.
